CALLIE SELLERS: Open Payments
NPI 1265293450 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 70 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $341 · 2025 $1,905
Food & beverage: $1,806Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $272 |
| CVRx, Inc. | 2 | $173 |
| Daiichi Sankyo Inc. | 2 | $145 |
| Merck Sharp & Dohme LLC | 7 | $135 |
| AstraZeneca Pharmaceuticals LP | 7 | $132 |
| Genentech USA, Inc. | 6 | $126 |
| SCPHARMACEUTICALS INC. | 4 | $96 |
| Janssen Biotech, Inc. | 4 | $80 |
| Lilly USA, LLC | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
Products named: Barostim Neo System, MONJUVI, Enhertu, FUROSCIX, VERQUVO, ERLEADA, FARXIGA, VERZENIO.
Industry payments across AL — which companies pay providers there.
